Literature DB >> 27989974

Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.

Atsushi Fukui1, Yoshihiro Muragaki2, Taiichi Saito3, Takashi Maruyama1, Masayuki Nitta1, Soko Ikuta4, Takakazu Kawamata5.   

Abstract

BACKGROUND: Extent of resection (EOR) remains controversial in therapy for glioblastoma (GBM). However, an increasing number of studies favor maximum EOR as being associated with longer patient survival. Residual tumor volume (RTV) has also recently emerged as a prognostic factor. Low-field intraoperative magnetic resonance imaging (iMRI) has contributed to improve the EOR of GBM. The purpose of this study was to analyze the relationships between EOR/RTV and overall survival (OS)/progression-free survival (PFS) in patients with newly diagnosed GBM using low-field iMRI.
METHODS: Adult patients who underwent surgery for newly diagnosed supratentorial GBM between 2000 and 2012 were retrospectively reviewed. Three-dimensional volumetric tumor measurements were made. Multivariate analysis was used to evaluate the relationships between EOR/RTV and OS/PFS.
RESULTS: Of 168 patients, 126 (75%) died and 154 (91%) showed tumor recurrence. Median OS and PFS for patients with iMRI were 19.3 months (95% confidence interval, 15.4-23.7 months) and 9.5 months (95% confidence interval, 7.8-10.8 months). Median preoperative tumor volume was 37.0 cm3 (interquartile range [IQR], 19.9-59.8 cm3). Median RTV was 0 cm3 (IQR, 0-1.6 cm3). Median EOR was 100% (IQR, 96.2%-100%). In multivariate analysis, after controlling for age and Karnofsky Performance Status, EOR and RTV remained significantly associated with survival (hazard ratio, 1.56; P = 0.018) and recurrence (hazard ratio, 1.53; P = 0.013). Maximum RTV for survival was 3 cm3.
CONCLUSIONS: This volumetric analysis for low-field iMRI showed that both EOR and RTV were significantly associated with survival and recurrence. We determined a threshold RTV of 3 cm3 as the maximum RTV associated with survival.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extent of resection; Glioblastoma; Intraoperative magnetic resonance imaging; Low field; Residual tumor volume; Threshold; Volumetry

Mesh:

Year:  2016        PMID: 27989974     DOI: 10.1016/j.wneu.2016.10.109

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  9 in total

1.  Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.

Authors:  Taiichi Saito; Yoshihiro Muragaki; Takashi Maruyama; Takashi Komori; Masayuki Nitta; Shunsuke Tsuzuki; Atsushi Fukui; Takakazu Kawamata
Journal:  Neurosurg Rev       Date:  2019-11-08       Impact factor: 3.042

2.  Recombinant adenovirus expressing a dendritic cell-targeted melanoma surface antigen for tumor-specific immunotherapy in melanoma mice model.

Authors:  Li-Li Guo; Gang-Cheng Wang; Peng-Jie Li; Cui-Mei Wang; Lin-Bo Liu
Journal:  Exp Ther Med       Date:  2018-04-23       Impact factor: 2.447

3.  Mucosal thickening of the maxillary sinus is frequently associated with diffuse glioma patients and correlates with poor survival prognosis of GBM patients: comparative analysis to meningioma patients.

Authors:  Taiichi Saito; Yoshihiro Muragaki; Takashi Maruyama; Kayoko Abe; Takashi Komori; Kosaku Amano; Seiichiro Eguchi; Masayuki Nitta; Shunsuke Tsuzuki; Atsushi Fukui; Takakazu Kawamata
Journal:  Neurosurg Rev       Date:  2021-02-03       Impact factor: 3.042

Review 4.  Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection.

Authors:  Cordelia Orillac; Walter Stummer; Daniel A Orringer
Journal:  Neurosurgery       Date:  2021-10-13       Impact factor: 4.654

5.  Impact of awake mapping on overall survival and extent of resection in patients with adult diffuse gliomas within or near eloquent areas: a retrospective propensity score-matched analysis of awake craniotomy vs. general anesthesia.

Authors:  Atsushi Fukui; Yoshihiro Muragaki; Taiichi Saito; Masayuki Nitta; Shunsuke Tsuzuki; Hidetsugu Asano; Takakazu Kawamata
Journal:  Acta Neurochir (Wien)       Date:  2021-10-04       Impact factor: 2.216

6.  Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study.

Authors:  Domenique M J Müller; Merijn E De Swart; Hilko Ardon; Frederik Barkhof; Lorenzo Bello; Mitchel S Berger; Wim Bouwknegt; Wimar A Van den Brink; Marco Conti Nibali; Roelant S Eijgelaar; Julia Furtner; Seunggu J Han; Shawn Hervey-Jumper; Albert J S Idema; Barbara Kiesel; Alfred Kloet; Emmanuel Mandonnet; Pierre A J T Robe; Marco Rossi; Tommaso Sciortino; W Peter Vandertop; Martin Visser; Michiel Wagemakers; Georg Widhalm; Marnix G Witte; Philip C De Witt Hamer
Journal:  Neurooncol Adv       Date:  2021-04-08

7.  Application of intraoperative B-mode ultrasound and shear wave elastography for glioma grading.

Authors:  Lu Yin; Linggang Cheng; Fumin Wang; Xueli Zhu; Yue Hua; Wen He
Journal:  Quant Imaging Med Surg       Date:  2021-06

8.  Intraoperative Photodynamic Diagnosis Using Talaporfin Sodium Simultaneously Applied for Photodynamic Therapy against Malignant Glioma: A Prospective Clinical Study.

Authors:  Kazuhide Shimizu; Masayuki Nitta; Takashi Komori; Takashi Maruyama; Takayuki Yasuda; Yu Fujii; Ken Masamune; Takakazu Kawamata; Taketoshi Maehara; Yoshihiro Muragaki
Journal:  Front Neurol       Date:  2018-01-30       Impact factor: 4.003

Review 9.  Glioblastoma Treatments: An Account of Recent Industrial Developments.

Authors:  Edouard Alphandéry
Journal:  Front Pharmacol       Date:  2018-09-13       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.